Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 120 clinical trials
A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC (TOP2101)

This is a research study to find out the safety and tolerability of combining the drug evolucumab with standard immunotherapy in people with advanced lung cancer (a type called non-small cell lung cancer). Nivolumab (Opdivo™) and ipilimumab (Yervoy™) are immunotherapy-type drugs which are approved for the treatment of advanced lung …

  • 0 views
  • 03 Jun, 2022
  • 1 location
Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases

will explore the efficacy of L- Annamycin as a single agent for the treatment of subjects with STS with lung metastases for which chemotherapy is considered appropriate.

cancer chemotherapy
  • 0 views
  • 29 Apr, 2022
  • 5 locations
BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases

This is a Phase 2 study of an investigational drug, BIO-11006, for the treatment of lung metastases in pediatric patients with advanced osteosarcoma or Ewing's sarcoma. This study will enroll up

  • 0 views
  • 30 May, 2022
  • 1 location
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

This phase I/Ib trial studies the side effects and best dose of alisertib when given together with osimertinib in treating patients with EGFR-mutated stage IV lung cancer. Alisertib may stop the growth of tumor cells by blocking a specific protein (Aurora Kinase A) that researchers believe may be important for …

ct scan
EGFR
cancer
neutrophil count
measurable disease
  • 0 views
  • 31 May, 2021
  • 1 location
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer

This phase III trial studies immunotherapy and stereotactic body radiation therapy to see how well it works compared with immunotherapy alone after first-line systemic therapy (therapy that goes throughout the body) in treating patients with stage IV non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help …

stereotactic radiation
neutrophil count
cancer
stereotactic body radiation
lung cancer
  • 0 views
  • 05 Jun, 2022
  • 1 location
Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

metastasis. We hope that it can reduce tumor recurrence and lung metastasis through this study.

ct scan
tumor recurrence
  • 12 views
  • 06 Feb, 2022
  • 1 location
Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Objectives Our specific aims are to: Aim 1: Examine the feasibility of a couple-based meditation program in 50 patients with metastatic lung cancer and

lung cancer
cancer
stage iv non-small cell lung cancer
lung carcinoma
Accepts healthy volunteers
  • 0 views
  • 24 Feb, 2022
  • 1 location
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest

doxorubicin
localized disease
cancer
systemic therapy
methotrexate
  • 0 views
  • 25 Jul, 2022
  • 44 locations
Pulmonary Resectable Metastases of Osteosarcoma With Apatinib and CHemotherapy (PROACH)

The aim of this study is to evaluate the efficacy and safety of Second-line chemotherapy combined with Apatinib for the patients with resectable pulmonary metastasis of osteosarcoma.

gemcitabine
docetaxel
apatinib
metastasis
treatment consisted of
  • 0 views
  • 16 May, 2022
  • 1 location
Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis

The investigators aim to optimize the radiation treatment of early stage lung cancer patients. Therefore, detailed understanding is needed of the type of toxicity and the location of these toxicities for patients who receive high fraction doses. These have not been measured in these patients before, therefore our primary research …

  • 0 views
  • 22 Jul, 2021
  • 3 locations